Shares of SenesTech Inc (NASDAQ:SNES) have earned an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.
Brokerages have set a twelve-month consensus price objective of $2.50 for the company, according to Zacks. Zacks has also assigned SenesTech an industry rank of 63 out of 256 based on the ratings given to its competitors.
Separately, ValuEngine raised shares of SenesTech from a “hold” rating to a “buy” rating in a report on Friday, June 28th.
Shares of SNES stock traded down $0.04 during mid-day trading on Friday, reaching $1.37. The company’s stock had a trading volume of 83,419 shares, compared to its average volume of 293,691. The firm’s 50 day moving average is $1.52. SenesTech has a 12-month low of $0.55 and a 12-month high of $1.95. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 2.76. The stock has a market cap of $40.98 million, a price-to-earnings ratio of -2.17 and a beta of 1.76.
SenesTech (NASDAQ:SNES) last issued its earnings results on Wednesday, May 15th. The company reported ($0.10) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.10). The business had revenue of $0.02 million for the quarter. SenesTech had a negative net margin of 3,908.08% and a negative return on equity of 186.65%. On average, equities research analysts predict that SenesTech will post -0.19 EPS for the current fiscal year.
In other news, CEO Kenneth S. Siegel purchased 696,296 shares of the stock in a transaction that occurred on Tuesday, July 16th. The stock was acquired at an average cost of $1.35 per share, with a total value of $939,999.60. Following the acquisition, the chief executive officer now owns 702,558 shares in the company, valued at $948,453.30. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 10.91% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in SNES. Virtu Financial LLC grew its holdings in SenesTech by 87.4% during the 1st quarter. Virtu Financial LLC now owns 56,447 shares of the company’s stock valued at $69,000 after purchasing an additional 26,322 shares in the last quarter. Meitav Dash Investments Ltd. acquired a new position in SenesTech during the 1st quarter worth $81,000. First Interstate Bank acquired a new position in SenesTech during the 2nd quarter worth $31,000. Finally, MRA Associates USA LLC acquired a new position in SenesTech during the 2nd quarter worth $46,000. 6.78% of the stock is owned by institutional investors and hedge funds.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.
Recommended Story: How does quantitative easing work?
Get a free copy of the Zacks research report on SenesTech (SNES)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.